This article provides a comprehensive overview of digital PCR (dPCR) and its transformative role in liquid biopsy for researchers and drug development professionals.
This article provides a comprehensive overview of circulating tumor DNA (ctDNA) and digital PCR (dPCR) for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of the cost-effectiveness of evolving cancer testing modalities, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis for researchers and drug development professionals on the two primary methodologies for detecting microsatellite instability (MSI) and mismatch repair deficiency (dMMR)—immunohistochemistry (IHC) and molecular...
This article provides a comprehensive performance evaluation of large (comprehensive) versus focused (limited) gene panels in oncology next-generation sequencing.
Accurate detection of oncogenic gene fusions is critical for cancer classification, prognosis, and targeted therapy.
This article provides a comprehensive comparative analysis of mutation calling algorithms, addressing a critical need in genomics research and clinical diagnostics.
This article provides a comprehensive analysis of the concordance between tissue and liquid biopsy for genomic profiling in cancer.
This article provides a detailed comparison of digital PCR (dPCR) and quantitative real-time PCR (qPCR) for liquid biopsy applications, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of the sensitivity and specificity profiles of current and emerging cancer testing platforms, tailored for researchers, scientists, and drug development professionals.